Dr. Ken Gillman is a retired clinical psychiatrist and neuropharmacologist who has published extensively in the field of serotonin toxicity (serotonin syndrome) and the clinical use and pharmacology of monoamine oxidase inhibitors (MAOIs), a class of medication used to treat depression, about which he is regarded as a leading expert. He has an H index of 27 and a citation total of over 3500. He maintains the free educational website psychopharmacology.com which concentrates on the above subjects.
Publications of Ken Gillman, M.D.
No publications found.
Explore our library of over 440 video lectures, podcasts, research summaries and expert interviews.
